NO20010089L - Farmasöytisk levotyroksinpreparat - Google Patents

Farmasöytisk levotyroksinpreparat

Info

Publication number
NO20010089L
NO20010089L NO20010089A NO20010089A NO20010089L NO 20010089 L NO20010089 L NO 20010089L NO 20010089 A NO20010089 A NO 20010089A NO 20010089 A NO20010089 A NO 20010089A NO 20010089 L NO20010089 L NO 20010089L
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical
pharmaceutical levothyroxine
levothyroxine preparation
excipients
Prior art date
Application number
NO20010089A
Other languages
English (en)
Other versions
NO20010089D0 (no
Inventor
Sven Alexander Schreder
Marion Nischwitz
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20010089L publication Critical patent/NO20010089L/no
Publication of NO20010089D0 publication Critical patent/NO20010089D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oppfinnelsen vedrører et farmasøytisk preparat som inneholder levotyroksinnatrium, kaliumjodid, mikrokrystallinsk cellulose og bindemidler, og som er fritt for antioksidanter eller andre hjelpestoffer, samt fremgangsmåte for fremstilling av preparatet.
NO20010089A 1998-07-07 2001-01-05 Farmasöytisk levotyroksinpreparat NO20010089D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830246A DE19830246A1 (de) 1998-07-07 1998-07-07 Pharmazeutische Zubereitung
PCT/EP1999/004485 WO2000002586A1 (de) 1998-07-07 1999-06-29 Pharmazeutische levothyroxinzubereitung

Publications (2)

Publication Number Publication Date
NO20010089L true NO20010089L (no) 2001-01-05
NO20010089D0 NO20010089D0 (no) 2001-01-05

Family

ID=7873182

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010089A NO20010089D0 (no) 1998-07-07 2001-01-05 Farmasöytisk levotyroksinpreparat

Country Status (18)

Country Link
US (1) US6491946B1 (no)
EP (1) EP1094841B1 (no)
JP (1) JP2002520296A (no)
KR (1) KR20010071765A (no)
CN (1) CN1307486A (no)
AR (1) AR019899A1 (no)
AT (1) ATE273697T1 (no)
AU (1) AU751575B2 (no)
BR (1) BR9911884A (no)
CA (1) CA2336748A1 (no)
CZ (1) CZ296897B6 (no)
DE (2) DE19830246A1 (no)
HU (1) HUP0104985A3 (no)
ID (1) ID27150A (no)
NO (1) NO20010089D0 (no)
PL (1) PL344834A1 (no)
SK (1) SK20042000A3 (no)
WO (1) WO2000002586A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
JP2004525109A (ja) 2001-02-15 2004-08-19 キング・ファーマシューティカルズ・インコーポレイティッド 安定化された甲状腺ホルモン医薬組成物、及びその製法
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030194436A1 (en) * 2001-08-10 2003-10-16 Franz Andrew G. Immediate release pharmaceutical compositions
US20030199585A1 (en) * 2001-08-10 2003-10-23 Franz G Andrew Levothyroxine compositions and methods
US20030195254A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030099699A1 (en) * 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
US7192657B2 (en) * 2003-04-15 2007-03-20 3M Innovative Properties Company Ethynyl containing electron transport dyes and compositions
AU2005322023A1 (en) * 2004-12-27 2006-07-06 King Pharmaceuticals Oxygen-impervious packaging and methods for storing thyroid hormone
US7858663B1 (en) 2007-10-31 2010-12-28 Pisgah Laboratories, Inc. Physical and chemical properties of thyroid hormone organic acid addition salts
US20150017236A1 (en) * 2013-07-09 2015-01-15 Jefferson J. Gregory Pharmaceutical compositions of thyroid hormone
US20200046664A1 (en) 2016-10-10 2020-02-13 Ftf Pharma Private Limited Method for preparation of liquid oral composition of l-thyroxin
DE102017122807B4 (de) 2017-09-29 2023-02-09 Berlin-Chemie Ag Orales Schilddrüsentherapeutikum
GEP20217241B (en) 2017-02-03 2021-04-12 Berlin Chemie Ag Oral thyroid therapeutic agent
KR20240039868A (ko) * 2022-09-20 2024-03-27 한국유나이티드제약 주식회사 갑상선 보호용 약학조성물 및 이의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
DE19541128C2 (de) * 1995-10-27 1997-11-27 Henning Berlin Gmbh & Co Stabilisierte schilddrüsenhormonhaltige Arzneimittel
US5635209A (en) * 1995-10-31 1997-06-03 Vintage Pharmaceuticals, Inc. Stabilized composition of levothyroxine sodium medication and method for its production
AU712217B2 (en) 1995-11-14 1999-11-04 Abbott Gmbh & Co. Kg Stabilized thyroid hormone preparations and methods of making same
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine

Also Published As

Publication number Publication date
CA2336748A1 (en) 2000-01-20
AU751575B2 (en) 2002-08-22
CN1307486A (zh) 2001-08-08
US6491946B1 (en) 2002-12-10
PL344834A1 (en) 2001-11-19
EP1094841A1 (de) 2001-05-02
ATE273697T1 (de) 2004-09-15
CZ200174A3 (en) 2001-05-16
WO2000002586A1 (de) 2000-01-20
ID27150A (id) 2001-03-08
AU4779399A (en) 2000-02-01
AR019899A1 (es) 2002-03-20
DE59910298D1 (de) 2004-09-23
EP1094841B1 (de) 2004-08-18
HUP0104985A3 (en) 2003-03-28
DE19830246A1 (de) 2000-01-13
NO20010089D0 (no) 2001-01-05
HUP0104985A2 (hu) 2002-04-29
CZ296897B6 (cs) 2006-07-12
SK20042000A3 (sk) 2001-09-11
JP2002520296A (ja) 2002-07-09
BR9911884A (pt) 2001-03-27
KR20010071765A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
ES2165833T1 (es) Composicion farmaceutica revestida enterica y procedimiento de fabricacion.
FI20011852A7 (fi) Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi
HUP9802086A2 (hu) Piperidino-alkanol vegyületeket tartalmazó gyógyszerkészítmények
AR003476A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol
MX9705383A (es) Compuesto que tienen efectos sobre los sistemas relacionados con la serotonina.
BR0109736A (pt) Preparação farmacêutica estabilizada, e, método para a manufatura de uma preparação farmacêutica em tablete
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
YU56995A (sh) Soli derivata indola
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
BR9911884A (pt) Preparação farmacêutica
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
FI973733A0 (fi) Farmaceutiskt preparat och foerfarande foer dess framstaellning
NO962187D0 (no) Sammensetninger som inhiberer apoptose, fremgangsmåter for rensing av sammensetningene og anvendelse derav
ATE423562T1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
ES2184881T3 (es) Composicion farmaceutica de ester etilico de l-dopa.
PT1414816E (pt) Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
ATE186462T1 (de) Gepirone enthaltende zusammensetzungen
WO1990009993A3 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
ES2104808T3 (es) Derivados de 4,13-dioxabiciclo(8.2.1.)tridecenona, procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.
NO20005758D0 (no) Farmasöytisk preparat som inneholder levotyroksin-natrium
PT90661A (pt) Processo para a preparacao de composicoes farmaceuticas contendo inibidores da enzima conversora de angiotensina e moduladores de canal de potassio
NO992999L (no) Farmasöytisk blanding for oral administrering
GB2390198A (en) Method and apparatus for migration of open network connections
GB9710725D0 (en) Process

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application